Login to Your Account

Other News To Note

Thursday, January 13, 2011
Inovio Pharmaceuticals Inc., of Blue Bell, Pa., published positive preclinical results for its Chikungunya virus vaccine in PloS Neglected Tropical Diseases. The vaccine protected mice against the virus and induced neutralizing antibodies in mice and nonhuman primates.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription